Shanghai Taiheng Industry Co., Ltd. - March 6, 2009

$117.00
The current synthesis process for the crude active pharmaceutical ingredient (API) lacks documented evidence that the critical process parameters are adequately identified, bracketed, and controlled to assure a consistent and reproducible process route that results in pre-defined API quality attributes.